IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

IRIDEX Corporation

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Plus Therapeutics (PSTV) and Iridex (IRIX) with bull...

Market Cap	$20.22M	P/E Ratio	NaN
52W High	$1.65	52W Low	$0.87
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	17.9%	52W Position	22.0%
Overall Score	39	Value Score	60
Quality Score	34	Technical Score	25

EPS Current Est	$NA	EPS Next Est	$NA
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	IRIX	$1.04	+2.97%	102.43K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	IRIX	$1.04	+3.0%	102.43K
3
4
5
6

IRIX

IRIX

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get IRIDEX Corporation Data in Excel

Get IRIDEX Corporation Data in Excel